Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2011-07-19
2011-07-19
Ketter, James S (Department: 1636)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009300, C435S006120
Reexamination Certificate
active
07981399
ABSTRACT:
The present invention relates to a method for determining the ideal time for and outcome of reproductive health procedures including in vitro fertilization by establishing a correlation between the successful outcome of said procedure and the spectra of a body fluid obtained using a chosen analytical modality for a population of patients, acquiring for a patient a spectrum of the body fluid of the patient using said chosen modality.
REFERENCES:
patent: 5541081 (1996-07-01), Hardy et al.
patent: 5912179 (1999-06-01), Alvarez et al.
patent: 6489135 (2002-12-01), Parrott et al.
patent: 6618138 (2003-09-01), Khoury
patent: 6683455 (2004-01-01), Ebbels et al.
patent: 6690958 (2004-02-01), Walker et al.
patent: 6873914 (2005-03-01), Winfield et al.
patent: 7005255 (2006-02-01), Kaddurah-Daouk et al.
patent: 7191068 (2007-03-01), Rosenfeld et al.
patent: 7202395 (2007-04-01), Leese et al.
patent: 2002/0188424 (2002-12-01), Hoffman et al.
patent: 2003/0014420 (2003-01-01), Jessee et al.
patent: 2003/0023386 (2003-01-01), Aranibar et al.
patent: 2003/0030637 (2003-02-01), Grinstein et al.
patent: 2003/0134304 (2003-07-01), van der Greef et al.
patent: 2003/0137649 (2003-07-01), Riordan et al.
patent: 2003/0229451 (2003-12-01), Hamilton et al.
patent: 2004/0002842 (2004-01-01), Woessner et al.
patent: 2004/0018500 (2004-01-01), Glassbrook et al.
patent: 2004/0018501 (2004-01-01), Allen et al.
patent: 2004/0019429 (2004-01-01), Coffin et al.
patent: 2004/0019430 (2004-01-01), Hurban et al.
patent: 2004/0019435 (2004-01-01), Winfield et al.
patent: 2004/0023295 (2004-02-01), Hamilton et al.
patent: 2004/0024293 (2004-02-01), Lawrence et al.
patent: 2004/0024543 (2004-02-01), Zhang et al.
patent: 2004/0033975 (2004-02-01), Fu et al.
patent: 2004/0072143 (2004-04-01), Timmis et al.
patent: 2004/0133355 (2004-07-01), Schneider et al.
patent: 2004/0143461 (2004-07-01), Watkins et al.
patent: 2004/0224301 (2004-11-01), Toland et al.
patent: 2004/0268446 (2004-12-01), Penttila et al.
patent: 2005/0014132 (2005-01-01), Kaddurah-Daouk et al.
patent: 2005/0143928 (2005-06-01), Moser et al.
patent: 2005/0154535 (2005-07-01), Sun et al.
patent: 2005/0170372 (2005-08-01), Afeyan et al.
patent: 2005/0239040 (2005-10-01), Lindenberg
patent: 2005/0273275 (2005-12-01), Afeyan et al.
patent: 2005/0283320 (2005-12-01), Afeyan et al.
patent: 2006/0160065 (2006-07-01), Timmis et al.
patent: 2007/0026389 (2007-02-01), Kaddurah-Daouk et al.
patent: 2007/0032969 (2007-02-01), Barrett et al.
patent: 2007/0043518 (2007-02-01), Nicholson et al.
patent: 2007/0054347 (2007-03-01), Rosendahl et al.
patent: 2007/0172820 (2007-07-01), Kaddurah-Daouk et al.
patent: 2007/0254309 (2007-11-01), O'Neill et al.
patent: 1248852 (2002-10-01), None
patent: WO 9916895 (1999-04-01), None
patent: WO 9963057 (1999-09-01), None
patent: WO 0132802 (2001-05-01), None
patent: WO 02087132 (2002-10-01), None
patent: WO 2005033895 (2005-04-01), None
patent: WO 2005052575 (2005-06-01), None
patent: WO 2006086731 (2006-08-01), None
patent: WO 2007035613 (2007-03-01), None
patent: WO 2007085851 (2007-08-01), None
patent: WO 2007109659 (2007-09-01), None
Ludwig et al., Experience with the elective transfer of two embryos under the conditions of the German embryo protection law: results of a retrospective data analysis of 2573 transfer cycles, Human Reproduction, 2000, 319-324, Vo.15, No. 2, European Society of Human Reproduction and Embryology.
Gributs et al., Haar transform analysis of photon time-of-flight measurements for quantification of optical properties in scattering media, Applied Optics, 2003, 2923-2930, vol. 42, No. 16, Optical Society of America.
Fuzzi et al., HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy, Eur. J. Immunol., 2002, 311-315, 32, Wiley-VCH Verlag GmbH, Weinheim.
McMaster et al., HLA-G isoforms produced by placenta cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation, The Journal of Immunology, 1998, 5922-5928, 160, The American Association of Immunologists.
McShane et al., Improving complex near-IR calibrations using a new wavelenght selection algorithm, Applied Spectroscopy, 1999, 1575-1581, vol. 53, No. 12, Society for Applied Spectroscopy.
Menicucci et al., Non-classic sHLA class I in human oocyte culture medium, Human Immunology, 1999, 1054-1057, 60, American Society for Histocompatibility and Immunogenetics, Elsevier Science Inc.
Sies, Oxidative stress II. Oxidants and Antioxidants, 1991, Academic Press, London.
Hailiwell et al., Free radicals in biology and medicine, 1999, 1632-1636, 3ed., Oxford:Oxford University Press Inc.
Almagor et al., Pregnancy rates after communal growth of preimplantation human embryos in vitro, Fertility and Sterility, 1996, 394-397, vol. 66, No. 3, American Society for Reproductive Medicine.
Gianaroli et al., Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos, Fertility and Sterility, 1997, 1128-1131, vol. 68, No. 6, American Society for Reproductive Medicine, Elsevier Science Inc.
Abu-Zidan et al., Proteolysis in severe sepsis is related to oxidation of plasma protein, Eur. J. Surg., 2002, 119-123, 168, Taylor & Francis.
Balaban et al., The effect of pronuclear morphology on embryo quality parameters and blastocyst transfer outcome, Human Reproduction, 2001, 2357-2361, vol. 16, No. 11, European Society of Human Reproduction and Embryology.
Le Bouteiller et al., The functionality of HLA-G is emerging, Immunological Reviews, 1999, 233-244, vol. 167, Munksgaard, Denmark.
Fish et al., The graduated Embryo Score (GES) predicts blastocyst formation and pregnancy rate from cleavage-stage embryos, Human Reproduction, 2001, 1970-1975, vol. 16, No. 9, European Society of Human Reproduction and Embryology.
Scott et al., The morphology of human pronuclear embryos is positively related to blastocyst development and implantation, Human Reproduction, 2394-2403, vol. 15, No. 11, European Society of Human Reproduction and Embryology, (2000).
Rijnders et al., The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in-vitro fertilization or intracytoplasmic sperm injection, Human Reproduction, 1998, 2869-2873, vol. 13, No. 10, European Society of Human Reproduction and Embryology.
Scott et al., The successful use of pronuclear embryo transfers the day following oocyte retrieval, Human Reproduction, 1998, 1003-1013, vol. 13, No. 4, European Society of Human Reproduction and Embryology.
Zollner et al., The use of a detailed zygote score after IVF/ICSI to obtain good quality blastocysts: the German experience, Human Reproduction, 2002, 1327-1333, vol. 17, No. 5, European Society of Human Reproduction and Embryology.
Fenwick et al., Time from insemination to first cleavage predicts development competence of human preimplantation embryos in vitro, Human Reproduction, 2002, 407-412, vol. 17, No. 2, European Society of Human Reproduction and Embryology.
Milki et al., Two-blastocyst transfer has similar pregnancy rates and a decreased multiple gestation rate compared with three-blastocyst transfer, Fertility and Sterility, 1999, 225-228, vol. 72, No. 2, American Society for Reproductive Medicine, Elsevier Science Inc.
Hunt et al., HLA and Fertility, HLA and the maternal-fetal Relationship, 1996, 134-156, R.G. Landes Company.
Loke et al., Human Implantation, Cell Biology and Immunology, 1995, 224-236, Cambridge, Cambridge University Press.
Spyropoulou et al., A prospective randomized study comparing the outcome of in-vitro fertilization and embryo transfer following culture of human embryos individually or in groups before embryo transfer on day 2, Human Reproduction, 1999, 76-79, vol. 14, No. 1, European Society of Human Reproduction and Embryology.
Levron et al., A prospective randomized study comparing day 3 with blastocyst-stage embryo transfer, Fertility and Sterility, 2002, 1300-1301, vol. 77, No. 6, American Society for Reproductive Med
Bereskin & Parr LLP / S.E.N.C.R.L., s.r.l.
Ketter James S
McGill University
LandOfFree
Method to determine state of a cell exchanging metabolites... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to determine state of a cell exchanging metabolites..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to determine state of a cell exchanging metabolites... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2627605